Citadel Advisors
AORT icon

Citadel Advisors’s Artivion AORT Stock Holding History

Citadel Advisors’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,500
Closed -$61.5K – 12413
2025
Q1 		$61.5K Buy
2,500
+200
+9% +$5.55K ﹤0.01% 12087
2024
Q4 		$65.8K Buy
2,300
+1,400
+156% +$38.8K ﹤0.01% 12060
2024
Q3 		$24K Sell
900
-5,900
-87% -$153K ﹤0.01% 12637
2024
Q2 		$174K Buy
6,800
+5,300
+353% +$119K ﹤0.01% 10128
2024
Q1 		$31.7K Sell
1,500
-4,400
-75% -$81.9K ﹤0.01% 12645
2023
Q4 		$105K Buy
5,900
+5,700
+2,850% +$88.6K ﹤0.01% 10866
2023
Q3 		$3.03K Sell
200
-300
-60% -$4.86K ﹤0.01% 13640
2023
Q2 		$8.6K Sell
500
-1,000
-67% -$14.7K ﹤0.01% 13310
2023
Q1 		$19.6K Buy
1,500
+1,000
+200% +$12.8K ﹤0.01% 13079
2022
Q4 		$6.06K Buy
+500
New +$6K ﹤0.01% 13947
2015
Q4 		– Sell
-1,800
Closed -$18K – 8696
2015
Q3 		$18K Buy
1,800
+500
+38% +$5.22K ﹤0.01% 8223
2015
Q2 		$15K Sell
1,300
-1,500
-54% -$15.9K ﹤0.01% 8282
2015
Q1 		$29K Buy
+2,800
New +$30.8K ﹤0.01% 7706

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Citadel Advisors's AORT Position: Q2 2026 in Review

Citadel Advisors increased its Artivion (AORT) stake by 1,068% in Q2 2026, buying an estimated $21.2M and bringing the position to 827,594 shares worth $18.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Citadel Advisors first reported a position in AORT in Q3 2013 and has held it in 40 quarters since. 207 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Citadel Advisors held 827,594 shares of Artivion worth $18.6M as of Q2 2026.
  • Citadel Advisors bought 756,725 Artivion shares in Q2 2026, an estimated $21.2M.
  • Artivion made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #2681 holding.
  • Citadel Advisors first reported a position in Artivion in Q3 2013 and has held it in 40 quarters since.
  • 207 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.